Impaired vasopressin suppression and enhanced atrial natriuretic hormone release following an acute water lead in primary aldosteronism

European Journal of Endocrinology

Volumn 137, Issue 2, 1997, Pages 154-161

  Kimura, Tokihisa ^a   Yamamoto, Tadasu ^a   Ohta, Masahiro ^a   Ota, Kozo ^a   Shoji, Masaru ^a   Funyu, Takeharu ^a   Mori, Takefumi ^a   Sahata, Takayuki ^a   Omata, Ken ^a   Abe, Keishi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HORMONE INHIBITION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; KIDNEY CLEARANCE; MALE; POTASSIUM METABOLISM; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SODIUM ABSORPTION; SODIUM METABOLISM; WATER LOADING;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; AGED; ARGININE VASOPRESSIN; ATRIAL NATRIURETIC FACTOR; BLOOD; DRINKING; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; NATRIURESIS; OSMOLAR CONCENTRATION; POSTOPERATIVE PERIOD; POTASSIUM; TIME FACTORS; URINE; VASOPRESSINS;

EID: 0030859035     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370154     Document Type: Article

References (26)

1. Berl T. Water metabolism in potassium depletion. Mineral and Electrolyte Metabolism 1980 4 209-215.
2. Horky K, Widlmsky J Jr, Hradec E, Gregorova I & Hradec M. Long-term results of surgical and conservative treatment of patients with primary aldosteronism. Experimental and Clinical Endocrinology 1987 90 337-346.
3. Mohring J, Mohring B, Petri M & Haack D, Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. American tournai of Physiology 1977 232 F260-F269.
4. Crofton JT, Share L, Shade RE, Lee-Kwon WJ, Manning M & Sawyer WH. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension 1979 1 31-38.
5. Padfield PL. Vasopressin in hypertension. American Heart Journal 1977 94 531-532.
6. Rutecki GW, Cox JW, Robertson GW, Francisco LL & Ferris TF. Urinary concentrating ability and antidiuretic hormone responsiveness in the potassium-depleted dog. Journal of Laboratory and Clinical Medicine 1982 100 53-60.
7. Yamaji T, Ishibashi M, Sekihara H, Takaku F, Nakaoka H & Fujii J. Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension. Journal of Clinical Endocrinology and Metabolism 1986 63 815-818.
8. Cappuccio FP, Markandu ND, Buckley MG, Sagnella GA, Shore AC & MacGregor GA. Changes in the plasma levels of atrial natriuretic peptides during mineralocorticoid escape in man. Clinical Science 1987 72 531-539.
9. Grekin RJ, Ling WD, Shenker Y & Bohr DF. Immunoreactive atrial natriuretic hormone levels increase in deoxycorticosterone acetate-treated pigs. Hypertension 1986 8 (Suppl II) II-16-II-20.
10. Inoue M, Kimura T, Ota K, Iitake K, Shoji M, Sato K. Ohta M & Yoshinaga K. Effect of vasopressin on atrial natriuretic peptide release and renal function in dogs. American Journal of Physiology 1988 255 E449-E455.
11. Inoue M, Kimura T, Ota K, Shoji M, Sato K, Ohta M, Yamamoto T & Yoshinaga K. Effect of atrial natriuretic peptide on the vasopressin response to osmotic and hemorrhagic stimuli in dogs. Journal of Neuroendocrinology 1990 2 903-909.
12. Kimura T, Abe K, Ota K, Omata K, Shoji M, Kudo K, Matsui K, Inoue M, Yasujima M & Yoshinaga K. Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans. Journal of Clinical Endocrinology and Metabolism 1986 62 1003-1010.
13. Kimura T, Matsui K, Ota K & Yoshinaga K. Radioimmunoassay of arginine vasopressin in human plasma and urine, a resin microcolumn method. Tohoku Journal of Experimental Medicine 1980 131 37-46.
14. Ghani M, Vincent DS & Richard MS. Effects of chronic sodium depletion on tubular sodium and water reabsorption in the dog. American Journal of Physiology 1974 227 469-476.
15. Sampanta B, Jay HS, Richard B, Richard WO, Willa H, Stanley C, David Y & Thomas FF. Effect of plasma sodium concentration on diluting segment sodium reabsorption. Kidney International 1974 5 1-11.
16. Wang BC, Share L, Crofton JT & Kimura T. Effect of intravenous and intracerebroventricular infusion of hypertonic solutions on plasma and cerebrospinal fluid vasopressin concentrations. Neuroendocrinology 1982 34 215-221.
17. Ota K, Kimura T, Matsui K, Iitake K, Shoji M, Inoue M, Sato K, Ohta M, Yamamoto T & Yoshinaga K. Effects of central osmotic stimulation on vasopressin and enkephalin release into the blood and cerebrospinal fluid and blood pressure. Acta Endocrinologica 1990 122 62-70.
18. Ferrario CM, Mohara O, Ueno Y & Brosnihan KB. Hemodynamic and neurohormonal changes in the development of DOC hypertension in the dog. American Journal of Medical Sciences 1988 295 352-359.
19. Shoji M, Kimura T, Matsui K, Ota K, Iitake K, Inoue M & Yoshinaga K. Role of intracerebral angiotensin receptors in the regulation of vasopressin release and the cardiovascular system. Neuroendocrinology 1986 43 239-244.
20. Keil LC, Summy-long J & Severs WB. Release of vasopressin by angiotensin II. Endocrinology 1975 96 1063-1065.
21. Dillingham MA & Anderson RJ. Inhibition of vasopressin action by atrial natriuretic factor. Science 1986 231 1572-1573.
22. Nonoguchi H, Sands JM & Knepper MA. Atrial natriuretic factor inhibits vasopressin-stimulated osmotic water permeability in rat inner medullary collecting duct. Journal of Clinical Investigation 1988 82 1383-1390.
23. Veress AT, Chong CK, Field LJ & Sonnenberg H. Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high-and low-salt diets. American Journal of Physiology 1995 269 R186-R192.
24. Koeppen BM. Mechanisms of segmental sodium and chloride reabsoption. In The Regulation of Sodium and Chloride Balance. pp 59-104. Eds DW Sedin & G Giebisch. New York: Raven Press Ltd. 1990.
25. Galvez OG, Bay WH, Roberts BW & Ferris TF. The hemodynamic effects of potassium deficiency in the dog. Circulation Research 1977 (Suppl 1) 401-11-1-16.
26. Nadler SP, Herbert SC & Brenner BM. PGE2, forskolin and cholera toxin interactions in rabbit cortical collecting tubule. American Journal of Physiology 1986 250 F127-F135.